ClinicalTrials.gov: NCT05929066 (TRIUMPH-1), NCT05931367 (TRIUMPH-4), NCT06354660 (TRANSCEND-T2D-1)
Pharmacol Rep 69:268275 Ali AMEA, Osman HM, Zaki AM, Shaker O, Elsayed AM, Abdelwahed MY, Mohammed RA (2022) Reno-protective effects of GLP-1 receptor agonist and anti-platelets in experimentally induced diabetic kidney disease in male albino rats
Staying hydrated, prioritizing protein, and maintaining balanced meals may help reduce these symptoms
When comparing Ozempic side effects vs Mounjaro side effects, reports suggest that Mounjaro users might experience slightly stronger gastrointestinal symptoms initially, possibly because of its dual-agonist action